UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Total revenue	$ 742.8	$ 638.9	$ 2,110.0	$ 1,822.3
Total cost of revenue	360.0	303.6	1,027.0	882.5
Gross profit	382.8	335.3	1,083.0	939.8
Operating expenses:
Selling, general and administrative	177.6	144.8	518.2	442.7
Research and development	71.3	56.2	211.3	172.4
Other charges, net	9.4	3.0	20.1	23.0
Total operating expenses	258.3	204.0	749.6	638.1
Operating income	124.5	131.3	333.4	301.7
Interest and other income (expense), net	(5.3)	(2.0)	(30.1)	(8.8)
Income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries	119.2	129.3	303.3	292.9
Income tax provision	30.8	41.2	80.6	93.0
Equity in income of unconsolidated investees, net of tax	0.3	0.3	1.2	0.3
Consolidated net income	88.7	88.4	223.9	200.2
Net income attributable to noncontrolling interests in consolidated subsidiaries	0.6	0.3	2.2	1.0
Net income attributable to Bruker Corporation	$ 88.1	$ 88.1	$ 221.7	$ 199.2
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.6	$ 0.6	$ 1.51	$ 1.34
Diluted	$ 0.6	$ 0.59	$ 1.5	$ 1.33
Weighted average common shares outstanding:
Basic	146.6	147.8	146.7	149.1
Diluted	147.3	148.6	147.5	149.9
Comprehensive income	$ 58.0	$ 44.6	$ 203.5	$ 113.7
Less: Comprehensive income (loss) attributable to noncontrolling interests	0.3	(0.3)	2.9	(0.5)
Less: Comprehensive loss attributable to redeemable noncontrolling interest	(0.8)	(0.6)	(1.1)	(1.3)
Comprehensive income attributable to Bruker Corporation	58.5	45.5	201.7	115.5
Product
Total revenue	615.1	536.6	1,741.8	1,512.8
Total cost of revenue	293.0	240.5	823.0	699.6
Other
Total revenue	127.7	102.3	368.2	309.5
Total cost of revenue	$ 67.0	$ 63.1	$ 204.0	$ 182.9